5-AZACITIDINE MAINTENANCE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT FOR PATIENTS WITH HIGH RISK AML AND MDS

被引：0
|
作者：
Puglisi, Bruna
Saraceni, Francesco
Guerzoni, Selene
Scortechini, Ilaria
Mancini, Giorgia
Fiorentini, Alessandro
Lotito, Antonio
Colaneri, Francesca Romana
Federici, Irene
Olivieri, Attilio
机构：
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P307
引用
收藏
页码：364 / 365
页数：2
相关论文
共 50 条
  • [21] Maintenance 5-Azactidine May Improve Outcomes after Allogeneic Stem-Cell Transplantation in High-Risk AML and MDS Patients
    Danylesko, Ivetta
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Nagler, Arnon
    Shimoni, Avichai
    BLOOD, 2019, 134
  • [22] Maintenance 5-Azactidine May Improve Outcomes after Allogeneic Stem-Cell Transplantation in High-Risk AML and MDS Patients
    Danylesko, Ivetta
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Nagler, Arnon
    Shimoni, Avichai
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S179 - S180
  • [23] Molecular Predictors of Outcome in Patients with MDS and AML Following MDS after Allogeneic Hematopoietic Stem Cell Transplantation
    Heuser, Michael
    Koenecke, Christian
    Gabdoulline, Razif
    Loeffeld, Patrick
    Dobbernack, Vera
    Panagiota, Victoria
    Klesse, Sabrina
    Stadler, Michael
    Krauter, Juergen
    Dammann, Elke
    Wichmann, Martin
    Shahswar, Rabia
    Bhuju, Sabin
    Geffers, Robert
    Schlegelberger, Brigitte
    Goehring, Gudrun
    Kleine, Moritz
    Brauns, Wiebke
    Platzbecker, Uwe
    Thiede, Christian
    Schroeder, Thomas
    Kobbe, Guido
    Ganser, Arnold
    Kroeger, Nicolaus
    Thol, Felicitas
    BLOOD, 2015, 126 (23)
  • [24] Maintenance therapy with Azacitidine for patients with myeloid malignancies after allogeneic hematopoietic stem cell transplantation
    Linli Lu
    Qian Cheng
    Yuhan Yan
    Xin Chen
    Yishu Tang
    Xin Li
    Scientific Reports, 15 (1)
  • [25] Novel Strategy for MDS with Thalidomide, 5-Azacitidine and Stem Cell Transplantaion
    Hayashi, Kunio
    Ikegame, Kazuhiro
    Ogawa, Hiroyasu
    BLOOD, 2012, 120 (21)
  • [26] T cell depleted (TCD) allogeneic hematopoietic stem cell transplant for older patients with advanced MDS and AML evolved from MDS
    Tamari, R.
    Chung, S.
    Devlin, S.
    Jakubowski, A.
    Papadopoulos, E.
    Perales, M. A.
    Ponce, D.
    Goldberg, J.
    Barker, J.
    Sauter, C.
    Koehne, G.
    Young, J.
    Giralt, S.
    Castro-Malaspina, H.
    LEUKEMIA RESEARCH, 2013, 37 : S122 - S122
  • [27] Azacitidine and donor lymphocyte infusion in relapsed AML or MDS after allogeneic stem cell transplant: a single-centre analysis
    Martinez-Cibrian, N.
    Dignan, F.
    Saif, M.
    Davis, E.
    Tholouli, E.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S390 - S391
  • [28] Effect of comorbidities on allogeneic hematopoietic stem cell transplant outcomes in AML/MDS patients in first complete remission
    Shahjahan, M
    Alamo, J
    de Lima, M
    Khouri, I
    Gajewski, J
    Andersson, B
    Champlin, R
    Giralt, SM
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 12 - 13
  • [29] REVISITING GVL EFFECT OF AZACITIDINE TREATMENT IN RELAPSED MDS PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Cho, S. G.
    Kim, S. Y.
    Cho, B. S.
    Kim, M.
    Eom, K. S.
    Kim, Y. J.
    Kim, H. J.
    Lee, S.
    Min, C. K.
    Kim, D. W.
    Lee, J. W.
    Min, W. S.
    Park, J. W.
    Kim, C. C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 281 - 281
  • [30] Maintenance Therapy with Chidamide Plus Azacitidine after Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Acute Myeloid Leukemia Patients
    Hu, Xiaohui
    Wu, Depei
    Chen, Suning
    Wu, Yaxue
    Zhang, Yang
    Bai, Lian
    Wu, Bing
    Zhou, Haixia
    Xu, Mingzhu
    Jiang, Shanshan
    Qian, Chongsheng
    Xue, Shengli
    BLOOD, 2023, 142
12345